Unknown

Dataset Information

0

Imidazopyridine-Based Thiazole Derivatives as Potential Antidiabetic Agents: Synthesis, In Vitro Bioactivity, and In Silico Molecular Modeling Approach.


ABSTRACT: A new series of thiazole derivatives (4a-p) incorporating imidazopyridine moiety was synthesized and assessed for their in vitro potential α-glucosidase potency using acarbose as a reference drug. The obtained results suggested that compounds 4a (docking score = -13.45), 4g (docking score = -12.87), 4o (docking score = -12.15), and 4p (docking score = -11.25) remarkably showed superior activity against the targeted α-glucosidase enzyme, with IC50 values of 5.57 ± 3.45, 8.85 ± 2.18, 7.16 ± 1.40, and 10.48 ± 2.20, respectively. Upon further investigation of the binding mode of the interactions by the most active scaffolds with the α-glucosidase active sites, the docking analysis was accomplished in order to explore the active cavity of the α-glucosidase enzyme. The interpretation of the results showed clearly that scaffolds 4a and 4o emerged as the most potent α-glucosidase inhibitors, with promising excellent binding interactions with the active site of the α-glucosidase enzyme. Furthermore, utilizing a variety of spectroscopic methods, such as 1H-NMR, 13C-NMR, and HREI-MS, the precise structures of the synthesized scaffolds were determined.

SUBMITTER: Hussain R 

PROVIDER: S-EPMC10535535 | biostudies-literature | 2023 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

Imidazopyridine-Based Thiazole Derivatives as Potential Antidiabetic Agents: Synthesis, In Vitro Bioactivity, and In Silico Molecular Modeling Approach.

Hussain Rafaqat R   Rehman Wajid W   Khan Shoaib S   Maalik Aneela A   Hefnawy Mohamed M   Alanazi Ashwag S AS   Khan Yousaf Y   Rasheed Liaqat L  

Pharmaceuticals (Basel, Switzerland) 20230913 9


A new series of thiazole derivatives (<b>4a-p</b>) incorporating imidazopyridine moiety was synthesized and assessed for their in vitro potential α-glucosidase potency using acarbose as a reference drug. The obtained results suggested that compounds <b>4a</b> (docking score = -13.45), <b>4g</b> (docking score = -12.87), <b>4o</b> (docking score = -12.15), and <b>4p</b> (docking score = -11.25) remarkably showed superior activity against the targeted α-glucosidase enzyme, with IC<sub>50</sub> val  ...[more]

Similar Datasets

| S-EPMC11650657 | biostudies-literature
| S-EPMC9835529 | biostudies-literature
| S-EPMC10209927 | biostudies-literature
| S-EPMC7504281 | biostudies-literature
| S-EPMC9917550 | biostudies-literature
| S-EPMC9653804 | biostudies-literature
| S-EPMC8624152 | biostudies-literature
| S-EPMC8307147 | biostudies-literature
| S-EPMC6868913 | biostudies-literature
| S-EPMC8072832 | biostudies-literature